Literature DB >> 25143294

Cognitive effects of very low nicotine content cigarettes, with and without nicotine replacement, in smokers with schizophrenia and controls.

Christopher G AhnAllen1, L Cinnamon Bidwell2, Jennifer W Tidey3.   

Abstract

INTRODUCTION: Beneficial effects of nicotine on cognitive functioning may contribute to the markedly high rates of smoking among people with schizophrenia. A reduction in the nicotine content of cigarettes to non-addictive levels is being considered as a regulatory strategy for reducing tobacco dependence in the United States. We examined whether switching to very low nicotine content (VLNC) cigarettes impairs cognitive functioning in smokers with and without schizophrenia, andwhether nicotine replacement reverses these effects.
METHODS: Smokers with schizophrenia (SS, n = 29) and control smokers matched on smoking rate but without psychiatric illness (CS, n = 28) smoked usual-brand cigarettes, VLNC cigarettes while wearing 2 placebo patches (PLA), or VLNC cigarettes while wearing 2 nicotine patches totaling 42mg (NIC) for 5hr, and then completed computerized assessments of visual sustained attention, motor speed, visual working memory, processing speed, inhibitory control, and response variability.
RESULTS: Across conditions, SS were slower than CS in tasks of motor speed and visual working memory, and had poorer target detectability on a visual sustained attention task. Across groups, functioning in domains of visual sustained attention, inhibitory control, processing speed, and response variability was impaired in the VLNC + PLA condition relative to the usual-brand and VLNC + NIC conditions.
CONCLUSIONS: Dramatically reducing the nicotine content of cigarettes may impair cognitive functioning in heavy smokers with and without schizophrenia, but the use of nicotine replacement while smoking VLNC cigarettes may preserve cognitive functioning in these smokers.
© The Author 2014. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25143294      PMCID: PMC4402354          DOI: 10.1093/ntr/ntu163

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  24 in total

1.  Effects of smoking abstinence, smoking cues and nicotine replacement in smokers with schizophrenia and controls.

Authors:  Jennifer W Tidey; Damaris J Rohsenow; Gary B Kaplan; Robert M Swift; Amy B Adolfo
Journal:  Nicotine Tob Res       Date:  2008-06       Impact factor: 4.244

2.  Tobacco regulatory science: research to inform regulatory action at the Food and Drug Administration's Center for Tobacco Products.

Authors:  David L Ashley; Cathy L Backinger; Dana M van Bemmel; Deborah J Neveleff
Journal:  Nicotine Tob Res       Date:  2014-03-17       Impact factor: 4.244

3.  The positive and negative syndrome scale (PANSS) for schizophrenia.

Authors:  S R Kay; A Fiszbein; L A Opler
Journal:  Schizophr Bull       Date:  1987       Impact factor: 9.306

4.  Establishing a nicotine threshold for addiction. The implications for tobacco regulation.

Authors:  N L Benowitz; J E Henningfield
Journal:  N Engl J Med       Date:  1994-07-14       Impact factor: 91.245

Review 5.  Schizophrenia and increased risks of cardiovascular disease.

Authors:  Charles H Hennekens; Alissa R Hennekens; Danielle Hollar; Daniel E Casey
Journal:  Am Heart J       Date:  2005-12       Impact factor: 4.749

6.  Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms.

Authors:  Kristi A Sacco; Angelo Termine; Aisha Seyal; Melissa M Dudas; Jennifer C Vessicchio; Suchitra Krishnan-Sarin; Peter I Jatlow; Bruce E Wexler; Tony P George
Journal:  Arch Gen Psychiatry       Date:  2005-06

7.  Effects of nicotine nasal spray on cognitive function in schizophrenia.

Authors:  Robert C Smith; Jessy Warner-Cohen; Melissa Matute; Erin Butler; Erin Kelly; Sumathi Vaidhyanathaswamy; Alea Khan
Journal:  Neuropsychopharmacology       Date:  2006-03       Impact factor: 7.853

8.  Relationship of cognition and psychopathology to functional impairment in schizophrenia.

Authors:  Somaia Mohamed; Robert Rosenheck; Marvin Swartz; Scott Stroup; Jeffrey A Lieberman; Richard S E Keefe
Journal:  Am J Psychiatry       Date:  2008-05-01       Impact factor: 18.112

9.  Neurocognitive deficit in schizophrenia: a quantitative review of the evidence.

Authors:  R W Heinrichs; K K Zakzanis
Journal:  Neuropsychology       Date:  1998-07       Impact factor: 3.295

Review 10.  What are the functional consequences of neurocognitive deficits in schizophrenia?

Authors:  M F Green
Journal:  Am J Psychiatry       Date:  1996-03       Impact factor: 18.112

View more
  20 in total

1.  Response to reduced nicotine content cigarettes among smokers differing in tobacco dependence severity.

Authors:  Stephen T Higgins; Cecilia L Bergeria; Danielle R Davis; Joanna M Streck; Andrea C Villanti; John R Hughes; Stacey C Sigmon; Jennifer W Tidey; Sarah H Heil; Diann E Gaalema; Maxine L Stitzer; Jeff S Priest; Joan M Skelly; Derek D Reed; Janice Y Bunn; Morgan A Tromblee; Christopher A Arger; Mollie E Miller
Journal:  Prev Med       Date:  2018-04-04       Impact factor: 4.018

2.  Nicotine Self-administration Is Not Increased in the Methylazoxymethanol Acetate Rodent Model of Schizophrenia.

Authors:  Jillian J Weeks; Laura E Rupprecht; Anthony A Grace; Eric C Donny; Alan F Sved
Journal:  Nicotine Tob Res       Date:  2020-02-06       Impact factor: 4.244

3.  Addiction Potential of Cigarettes With Reduced Nicotine Content in Populations With Psychiatric Disorders and Other Vulnerabilities to Tobacco Addiction.

Authors:  Stephen T Higgins; Sarah H Heil; Stacey C Sigmon; Jennifer W Tidey; Diann E Gaalema; John R Hughes; Maxine L Stitzer; Hanna Durand; Janice Y Bunn; Jeff S Priest; Christopher A Arger; Mollie E Miller; Cecilia L Bergeria; Danielle R Davis; Joanna M Streck; Derek D Reed; Joan M Skelly; Lauren Tursi
Journal:  JAMA Psychiatry       Date:  2017-10-01       Impact factor: 21.596

4.  Response to varying the nicotine content of cigarettes in vulnerable populations: an initial experimental examination of acute effects.

Authors:  Stephen T Higgins; Sarah H Heil; Stacey C Sigmon; Jennifer W Tidey; Diann E Gaalema; Maxine L Stitzer; Hanna Durand; Janice Y Bunn; Jeff S Priest; Christopher A Arger; Mollie E Miller; Cecilia L Bergeria; Danielle R Davis; Joanna M Streck; Ivori Zvorsky; Ryan Redner; Ryan Vandrey; Lauren R Pacek
Journal:  Psychopharmacology (Berl)       Date:  2016-10-06       Impact factor: 4.530

Review 5.  A review of the effects of very low nicotine content cigarettes on behavioral and cognitive performance.

Authors:  Diana R Keith; Allison N Kurti; Danielle R Davis; Ivori A Zvorsky; Stephen T Higgins
Journal:  Prev Med       Date:  2017-06-21       Impact factor: 4.018

6.  Minimal effects of prolonged smoking abstinence or resumption on cognitive performance challenge the "self-medication" hypothesis in schizophrenia.

Authors:  Douglas L Boggs; Toral S Surti; Irina Esterlis; Brian Pittman; Kelly Cosgrove; R Andrew Sewell; Mohini Ranganathan; Deepak Cyril D'Souza
Journal:  Schizophr Res       Date:  2017-04-06       Impact factor: 4.939

Review 7.  A review of tobacco regulatory science research on vulnerable populations.

Authors:  Stephen T Higgins; Allison N Kurti; Marissa Palmer; Jennifer W Tidey; Antonio Cepeda-Benito; Maria R Cooper; Nicolle M Krebs; Lourdes Baezconde-Garbanati; Joy L Hart; Cassandra A Stanton
Journal:  Prev Med       Date:  2019-05-02       Impact factor: 4.018

8.  Smoking Topography Characteristics of Very Low Nicotine Content Cigarettes, With and Without Nicotine Replacement, in Smokers With Schizophrenia and Controls.

Authors:  Jennifer W Tidey; Rachel N Cassidy; Mollie E Miller
Journal:  Nicotine Tob Res       Date:  2016-03-19       Impact factor: 4.244

Review 9.  Modeling nicotine regulation: A review of studies in smokers with mental health conditions.

Authors:  Jennifer W Tidey; Danielle R Davis; Mollie E Miller; Irene Pericot-Valverde; Rachel L Denlinger-Apte; Diann E Gaalema
Journal:  Prev Med       Date:  2018-07-03       Impact factor: 4.018

10.  Comparison of nicotine dependence indicators in predicting quitting among pregnant smokers.

Authors:  Allison N Kurti; Danielle R Davis; Joan M Skelly; Ryan Redner; Stephen T Higgins
Journal:  Exp Clin Psychopharmacol       Date:  2016-02       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.